| 26 Feb, 05:20 pm | — | … | Cipla Limited has informed the Exchange about ESG Rating. | nse |
| 21 Feb, 05:52 pm | — | … | Cipla Limited has informed the Exchange regarding 'Update on US Food and Drug Administration (USFDA) inspection on Pharmathen International S.A. '. | nse |
| 20 Feb, 05:57 pm | — | … | Cipla Ltd - 500087 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 10 Feb, 08:43 am | — | … | Cipla Ltd - 500087 - USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA | bse |
| 10 Feb, 08:42 am | — | … | Cipla Limited has informed the Exchange about General Updates | nse |
| 08 Feb, 10:25 pm | — | … | Cipla Ltd - 500087 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 08 Feb, 02:50 pm | — | … | Cipla Limited has informed the Exchange about General Updates | nse |
| 05 Feb, 06:46 pm | — | … | Cipla Ltd - 500087 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 05 Feb, 06:46 pm | — | … | Cipla Limited has informed the Exchange about General Updates | nse |
| 02 Feb, 10:09 am | — | … | Cipla Limited has informed the Exchange about change in Management | nse |
| 02 Feb, 10:07 am | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 28 Jan, 06:25 pm | — | … | Cipla Limited has informed the Exchange regarding allotment of 8879 securities pursuant to ESOP/ESPS at its meeting held on January 28, 2026 | nse |
| 27 Jan, 07:41 pm | — | … | Cipla Limited has informed the Exchange about Transcript | nse |
| 27 Jan, 07:41 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 23 Jan, 07:20 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 23 Jan, 07:14 pm | — | … | Cipla Limited has informed the Exchange about Link of Recording | nse |
| 23 Jan, 02:17 pm | — | … | Cipla Limited has informed the Exchange that the Board has approved the changes in the Key Managerial Personnels (KMPs) and Officers authorised under Regulation 30(5) of the SEBI Listing Regulations with effect from 1st April 2026. | nse |
| 23 Jan, 02:16 pm | — | … | Cipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,
2015 | bse |
| 23 Jan, 02:10 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 23 Jan, 02:09 pm | — | … | Cipla Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 23 Jan, 02:08 pm | — | … | Cipla Ltd - 500087 - Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 23Rd January, 2026 | bse |
| 23 Jan, 02:06 pm | — | … | Cipla Limited has informed the Exchange that the Board has approved the re-appointment of Mr P R Ramesh as Independent Director of the Company for a second term of five consecutive years, subject to approval of the shareholders. | nse |
| 23 Jan, 01:44 pm | — | … | Cipla Limited has informed the Exchange about Investor Presentation | nse |
| 23 Jan, 01:42 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 23 Jan, 01:41 pm | — | … | Cipla Limited has informed the Exchange regarding a press release dated January 23, 2026, titled "Q3 FY26 Results". | nse |
| 23 Jan, 01:40 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Jan, 01:27 pm | — | … | Cipla Ltd - 500087 - Financial Results For Quarter And Nine Months Ended 31St December, 2025 | bse |
| 23 Jan, 01:27 pm | — | … | Cipla Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 14 Jan, 11:11 pm | — | … | Cipla Ltd - 500087 - Update On Lanreotide Supply Pursuant To US Food And Drug Administration (USFDA) Inspectional Observations In Form 483 On Pharmathen International S.A. | bse |
| 14 Jan, 11:10 pm | — | … | Cipla Limited has informed the Exchange about General Updates | nse |
| 09 Jan, 04:40 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 07 Jan, 06:15 pm | — | … | The Exchange has sought clarification from Cipla Limited with respect to recent news item captioned Cipla shares fall 4% as partner gets US FDA observations. The response from the Company is attached. | nse |
| 07 Jan, 06:13 pm | — | … | Cipla Ltd - 500087 - Intimation Under Regulation 30(11) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Clarification On USFDA Inspectional Observations In Form 483 On Pharmathen International S.A. | bse |
| 07 Jan, 03:55 pm | — | … | The Exchange has sought clarification from Cipla Limited with respect to recent news item captioned Cipla shares fall 4% as partner gets US FDA observations. The response from the Company is awaited. | nse |
| 30 Dec, 03:13 pm | — | … | Cipla Limited has informed the Exchange about change in Management | nse |
| 30 Dec, 03:12 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 23 Dec, 08:25 pm | — | … | Cipla Ltd - 500087 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Friday, 23Rd January, 2026 Inter-Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December, 2025. | bse |
| 22 Dec, 07:10 pm | — | … | Cipla Ltd - 500087 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 22 Dec, 07:02 pm | — | … | Cipla Limited has informed the Exchange about General Updates | nse |
| 19 Dec, 11:30 am | — | … | Cipla Limited has informed the exchange that it has entered into an exclusive Supply and Marketing Agreement for Pfizer s brands | nse |
| 10 Dec, 04:04 pm | — | … | Update on launch of Yurpeak® (Tirzepatide) in India for the treatment of Obesity and Type 2 Diabetes | nse |
| 10 Dec, 01:13 pm | — | … | Cipla Ltd - 500087 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 10 Dec, 01:13 pm | — | … | Cipla Limited has informed the Exchange about General Updates | nse |
| 04 Dec, 10:24 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 04 Dec, 10:18 pm | — | … | Cipla Limited has informed the Exchange about Acquisition | nse |
| 01 Dec, 12:50 pm | — | … | Cipla Ltd - 500087 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 03 Nov, 04:37 pm | — | … | Cipla Limited has informed the Exchange about Transcript | nse |
| 03 Nov, 04:37 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 03 Nov, 03:42 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 03 Nov, 03:41 pm | — | … | Cipla Limited has informed the Exchange about Acquisition | nse |